FDA 483 - N-Molecular Inc. d.b.a. SOFIE - November 20, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
N-Molecular Inc. d.b.a. SOFIE in Haverhill, MA, a sterile PET drug producer, received a Form 483 with three observations. The inspection revealed significant issues including inadequate record-keeping for critical release tests, failure to follow quality assurance procedures for aseptic processing and material disinfection, and poor maintenance of equipment in critical production areas. These deficiencies indicate a high potential for product contamination and impact on drug quality.
ID · 888f9f04-32d7-49b6-8a60-498f4f7a86f0